Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroprotective Agents | 9 | 2021 | 245 | 2.000 |
Why?
|
| Diterpenes | 9 | 2023 | 92 | 1.910 |
Why?
|
| Hippocampus | 11 | 2021 | 561 | 1.530 |
Why?
|
| Cholinesterase Inhibitors | 3 | 2015 | 43 | 0.940 |
Why?
|
| Receptors, Nicotinic | 4 | 2012 | 106 | 0.780 |
Why?
|
| Nicotinic Antagonists | 4 | 2012 | 30 | 0.670 |
Why?
|
| Isoflurophate | 2 | 2015 | 10 | 0.650 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2023 | 1618 | 0.630 |
Why?
|
| Spermine | 8 | 2000 | 64 | 0.620 |
Why?
|
| Brain | 11 | 2015 | 1346 | 0.590 |
Why?
|
| N-Methylaspartate | 5 | 2012 | 57 | 0.530 |
Why?
|
| Neurosciences | 1 | 2015 | 28 | 0.520 |
Why?
|
| Synapses | 2 | 2015 | 180 | 0.500 |
Why?
|
| Research Personnel | 1 | 2015 | 155 | 0.480 |
Why?
|
| Research | 1 | 2015 | 163 | 0.480 |
Why?
|
| Rats | 24 | 2023 | 3483 | 0.470 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2013 | 35 | 0.440 |
Why?
|
| GABA Antagonists | 1 | 2012 | 29 | 0.440 |
Why?
|
| Paraoxon | 2 | 2015 | 9 | 0.430 |
Why?
|
| Animals | 36 | 2023 | 15081 | 0.400 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2003 | 48 | 0.400 |
Why?
|
| Acetylcholinesterase | 3 | 2015 | 55 | 0.350 |
Why?
|
| Brain Ischemia | 2 | 2023 | 184 | 0.310 |
Why?
|
| Putrescine | 4 | 1993 | 25 | 0.310 |
Why?
|
| Atropine | 3 | 2015 | 13 | 0.280 |
Why?
|
| Neurons | 6 | 2021 | 1175 | 0.270 |
Why?
|
| Electric Organ | 4 | 1999 | 18 | 0.240 |
Why?
|
| Environment | 5 | 1990 | 138 | 0.240 |
Why?
|
| Pralidoxime Compounds | 2 | 2015 | 5 | 0.230 |
Why?
|
| Muscle Proteins | 3 | 1999 | 51 | 0.230 |
Why?
|
| Cerebral Cortex | 7 | 2006 | 290 | 0.230 |
Why?
|
| Receptor, Bradykinin B2 | 2 | 2013 | 12 | 0.220 |
Why?
|
| Eflornithine | 3 | 1993 | 18 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 3 | 1999 | 360 | 0.190 |
Why?
|
| Male | 15 | 2023 | 20025 | 0.190 |
Why?
|
| Encephalitis | 1 | 2021 | 42 | 0.190 |
Why?
|
| Phencyclidine | 2 | 1999 | 19 | 0.190 |
Why?
|
| Hypoxia, Brain | 1 | 2000 | 7 | 0.180 |
Why?
|
| Stroke | 2 | 2015 | 286 | 0.180 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 220 | 0.170 |
Why?
|
| Exploratory Behavior | 5 | 1994 | 75 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2015 | 587 | 0.160 |
Why?
|
| Calcium Channel Blockers | 1 | 1997 | 56 | 0.150 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 282 | 0.150 |
Why?
|
| Biogenic Polyamines | 3 | 1993 | 7 | 0.140 |
Why?
|
| Action Potentials | 3 | 2013 | 231 | 0.140 |
Why?
|
| Organ Culture Techniques | 2 | 2013 | 103 | 0.140 |
Why?
|
| Calcium Channels | 2 | 1995 | 76 | 0.130 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2012 | 34 | 0.130 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2006 | 137 | 0.130 |
Why?
|
| Female | 9 | 2023 | 20969 | 0.130 |
Why?
|
| Bradykinin | 2 | 2013 | 22 | 0.130 |
Why?
|
| Pyridostigmine Bromide | 1 | 2015 | 5 | 0.130 |
Why?
|
| Parasympatholytics | 2 | 2011 | 6 | 0.130 |
Why?
|
| Receptors, Cholinergic | 3 | 2006 | 28 | 0.130 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 70 | 0.130 |
Why?
|
| Metabolome | 1 | 2015 | 53 | 0.120 |
Why?
|
| Peptides | 1 | 1997 | 320 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2006 | 286 | 0.120 |
Why?
|
| Calcium | 3 | 2006 | 480 | 0.120 |
Why?
|
| Spermidine | 3 | 1990 | 33 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 1039 | 0.110 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 8 | 0.110 |
Why?
|
| Torpedo | 5 | 1999 | 41 | 0.110 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2012 | 5 | 0.100 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2012 | 77 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 409 | 0.100 |
Why?
|
| Cell Survival | 1 | 2015 | 864 | 0.100 |
Why?
|
| Cholinesterase Reactivators | 1 | 2011 | 4 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 1993 | 314 | 0.100 |
Why?
|
| RNA | 3 | 1987 | 241 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 1371 | 0.100 |
Why?
|
| Rats, Inbred Strains | 5 | 1994 | 133 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2013 | 808 | 0.090 |
Why?
|
| Tromethamine | 1 | 1989 | 5 | 0.080 |
Why?
|
| Organ Size | 6 | 1994 | 157 | 0.080 |
Why?
|
| Ion Channel Gating | 3 | 1999 | 83 | 0.080 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2000 | 79 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 1989 | 66 | 0.080 |
Why?
|
| Neurotoxins | 2 | 2000 | 57 | 0.080 |
Why?
|
| Social Environment | 3 | 1994 | 207 | 0.070 |
Why?
|
| Kinetics | 2 | 1999 | 708 | 0.070 |
Why?
|
| Brain Chemistry | 3 | 2012 | 140 | 0.070 |
Why?
|
| Humans | 3 | 2015 | 37093 | 0.070 |
Why?
|
| Cebidae | 1 | 1985 | 4 | 0.070 |
Why?
|
| Saimiri | 1 | 1985 | 6 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 1987 | 103 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 63 | 0.070 |
Why?
|
| Object Attachment | 1 | 1985 | 24 | 0.070 |
Why?
|
| Acetylcholine | 2 | 1999 | 73 | 0.060 |
Why?
|
| Mice | 5 | 2021 | 5913 | 0.060 |
Why?
|
| Nicotine | 2 | 2006 | 257 | 0.060 |
Why?
|
| Synaptic Transmission | 2 | 1995 | 146 | 0.060 |
Why?
|
| Xenopus laevis | 3 | 1999 | 73 | 0.060 |
Why?
|
| Cytokines | 2 | 2021 | 602 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 269 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 1999 | 1180 | 0.050 |
Why?
|
| Selection, Genetic | 1 | 1980 | 54 | 0.040 |
Why?
|
| Ion Channels | 1 | 1999 | 71 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 132 | 0.040 |
Why?
|
| Point Mutation | 1 | 1999 | 93 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1999 | 191 | 0.040 |
Why?
|
| Avoidance Learning | 1 | 1980 | 62 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 1999 | 223 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 149 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 188 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 1999 | 265 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 1999 | 103 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 295 | 0.040 |
Why?
|
| Color | 2 | 1990 | 20 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 1568 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 933 | 0.040 |
Why?
|
| omega-Conotoxin GVIA | 1 | 1997 | 6 | 0.040 |
Why?
|
| Binding Sites | 1 | 1999 | 651 | 0.040 |
Why?
|
| Evoked Potentials | 2 | 1995 | 87 | 0.040 |
Why?
|
| Snake Venoms | 1 | 1977 | 3 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1518 | 0.040 |
Why?
|
| Cytotoxins | 1 | 1977 | 11 | 0.040 |
Why?
|
| Cell Line | 3 | 2015 | 1354 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1609 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1995 | 136 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 306 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 1995 | 184 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 58 | 0.030 |
Why?
|
| Injections | 1 | 1974 | 35 | 0.030 |
Why?
|
| Neuroglia | 1 | 2015 | 124 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1994 | 99 | 0.030 |
Why?
|
| Glucose | 2 | 2015 | 230 | 0.030 |
Why?
|
| DNA | 2 | 1987 | 574 | 0.030 |
Why?
|
| Cnidaria | 1 | 1993 | 8 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 1994 | 168 | 0.030 |
Why?
|
| Terpenes | 1 | 1993 | 28 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2012 | 14 | 0.030 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2012 | 6 | 0.030 |
Why?
|
| Catheterization | 1 | 2012 | 24 | 0.030 |
Why?
|
| Sodium Channels | 1 | 1993 | 67 | 0.030 |
Why?
|
| Body Weight | 3 | 1987 | 434 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2012 | 61 | 0.030 |
Why?
|
| Carboxypeptidases | 1 | 2012 | 7 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2012 | 128 | 0.030 |
Why?
|
| Polyamines | 1 | 1992 | 30 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 448 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 234 | 0.020 |
Why?
|
| Cyclohexylamines | 1 | 1990 | 12 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 1990 | 60 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 859 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 1990 | 40 | 0.020 |
Why?
|
| Cerebellum | 1 | 1990 | 73 | 0.020 |
Why?
|
| Aging | 1 | 1994 | 664 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 481 | 0.020 |
Why?
|
| Chemistry | 1 | 1989 | 17 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1989 | 54 | 0.020 |
Why?
|
| Rana pipiens | 1 | 1989 | 62 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 626 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1990 | 167 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2231 | 0.020 |
Why?
|
| Social Isolation | 2 | 1994 | 29 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2006 | 5 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 54 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2006 | 82 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 153 | 0.020 |
Why?
|
| Social Behavior | 1 | 1985 | 131 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 623 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2006 | 928 | 0.010 |
Why?
|
| Organ Specificity | 2 | 1993 | 129 | 0.010 |
Why?
|
| Oocytes | 2 | 1993 | 146 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1993 | 515 | 0.010 |
Why?
|
| Arousal | 1 | 1979 | 86 | 0.010 |
Why?
|
| Models, Structural | 1 | 1977 | 9 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2006 | 1908 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1977 | 152 | 0.010 |
Why?
|
| Motor Activity | 1 | 1979 | 418 | 0.010 |
Why?
|
| Sensory Deprivation | 1 | 1974 | 7 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1974 | 33 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1994 | 5 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1974 | 55 | 0.010 |
Why?
|
| Mental Recall | 1 | 1994 | 78 | 0.010 |
Why?
|
| Receptors, AMPA | 1 | 1994 | 56 | 0.010 |
Why?
|
| Nucleus Accumbens | 1 | 1994 | 82 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1994 | 112 | 0.010 |
Why?
|
| Tetracaine | 1 | 1993 | 4 | 0.010 |
Why?
|
| Cnidarian Venoms | 1 | 1993 | 23 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1973 | 103 | 0.010 |
Why?
|
| Research Design | 1 | 1974 | 313 | 0.010 |
Why?
|
| Magnesium | 1 | 1993 | 97 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1993 | 223 | 0.010 |
Why?
|
| Rubidium | 1 | 1992 | 6 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1994 | 353 | 0.010 |
Why?
|
| Bungarotoxins | 1 | 1992 | 21 | 0.010 |
Why?
|
| Carbachol | 1 | 1992 | 19 | 0.010 |
Why?
|
| Water | 1 | 1974 | 296 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 111 | 0.010 |
Why?
|
| Ligands | 1 | 1993 | 349 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1993 | 492 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1970 | 63 | 0.010 |
Why?
|
| Time Factors | 1 | 1974 | 1742 | 0.010 |
Why?
|
| Protein Binding | 1 | 1993 | 972 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1992 | 381 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 1970 | 216 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1973 | 38 | 0.000 |
Why?
|
| Culture Media | 1 | 1973 | 90 | 0.000 |
Why?
|